Risk-Stratified Treatment in Chronic Lymphocytic Leukemia

November 6, 2015

Learning Objectives

  • Assess risk and monitor response to treatment by combining classic leukemia staging methods with novel pathology biomarkers and prognostic factors
  • Discuss strategies for managing side effects of novel therapies, as well as preventing infections
  • Describe best practices for optimizing selection and sequencing of treatments in the upfront and relapsed/refractory settings
  • Explain the role of the Advanced Practitioner as a member of the collaborative practice team in caring for patients with CLL through the trajectory of their illness
Course summary
Available credit: 
  • 1.00 AANP
  • 0.67 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/06/2015
Course expires: 
02/29/2016
Event starts: 
11/06/2015 - 4:40pm
Event ends: 
11/06/2015 - 5:40pm
Cost:
$0.00
Parent activity set: 
Concurrent Sessions 4:40-5:40PM
Add to calendar: 
Rating: 
0
United States

Amy Goodrich, MSN, CRNP
Deborah M. Stephens, DO

Available Credit

  • 1.00 AANP
  • 0.67 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.